Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.

Tofacitinib may help regrow hair in alopecia areata patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

CTP-543 is generally safe for treating alopecia areata.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Abatacept may help some people with alopecia areata regrow hair.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.